MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Henry Schein adds luster to strong 2010 with record Q4
Henry Schein Inc. (NSDQ:HSIC) reported profits of $93.0 million, or $1.00 per diluted share, on sales of $2.02 billion during the three months ended Dec. 25, 2010. That compares with profits of $86.4 million, or 94 cents per diluted share, on sales of $1.79 billion during the same period in 2009.
Full-year profits were $325.8 million, or $3.49 per diluted share, on sales of $7.53 billion. That compares with profits of $311.2 million, or $3.44 per diluted share, on sales of $6.54 billion in 2009.
Read more
CardioNet trims losses despite lower sales
CardioNet Inc. (NSDQ:BEAT) reported a loss of $4.8 million, or 20 cents per diluted share, on sales of $28.7 million during the three months ended Dec. 31. That compares with a loss of $16.0 million, or 67 cents per diluted share, on sales of $33.3 million during the same period last year.
Full-year losses were $19.9 million, or 82 cents per diluted share, on sales of $119.9 million. That compares with a loss of $20.5 million, or 86 cents per diluted share, on sales of $140.6 million in 2009.
Read more
Endologix Q4 profits rescue 2010
Endologix Inc. (NSDQ:ELGX) reported profits of $8.0 million or 15 cents per diluted share, on sales of $19.2 million during the three months ended Dec. 31. That compares with a loss of $676,000, or 1 cent per diluted share, on sales of $13.7 million during the same period last year.
Full-year profits were $6.9 million, or 14 cents per diluted share, on sales of $67.3 million. That compares with a loss of $2.4 million, or 5 cents per diluted share, on sales of $52.4 million in 2009.
Read more
Solta Medical losses ease as sales rise
Solta Medical Inc. (NSDQ:SLTM) reported a loss of $190,000, or less than 1 cent per diluted share, on sales of $30.1 million during the three months ended Dec. 31. That compares with a loss of $256,000, or 1 cent per diluted share, on sales of $28.4 million during the same period in 2009.
Full-year losses were $2.0 million, or 3 cents per diluted share, on sales of $110.9 million. That compares with losses of $11.2 million, or 23 cents per diluted share, on sales of $98.8 million in 2009.
Read more
China Medical Q3 profits jump 72 percent
China Medical Technologies Inc. (NSDQ:CMED) reported a profit of $11.5 million, or 43 cents per diluted share, on sales of $33.9 million during the three months ended Dec. 31, 2010. That compares with a profit of $6.7 million, or 25 cents per diluted share, on sales of $32.8 million during the same period in 2009, based on an average currency exchange rate for the three months.
Read more
